Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitorsTommaso Clemente, Antonella Castagna, Maurizio Zazzi et al.|BMJ Open|2024Cited by 21
Risk of virological failure after drug burden reduction in people with 4-class drug-resistant HIV on virological suppression: A retrospective cohort analysis of data from the PRESTIGIO RegistryTommaso Clemente, Vincenzo Spagnuolo, Riccardo Lolatto et al.|International Journal of Antimicrobial Agents|2024Cited by 3
Sexually transmitted infections in people with multidrug-resistant HIVTommaso Clemente, Vincenzo Spagnuolo, Rebecka Papaioannu Borjesson et al.|AIDS|2023Cited by 2
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO RegistryDaniele Armenia, Silvia Magnani, Maurizio Zazzi et al.|Journal of Antimicrobial Chemotherapy|2025Cited by 0